Physician

Saira Bilal, M.D.

According to 2025 Medicare claims, Saira Bilal, M.D. (NPI: 1770899627) practices rheumatology in the Arlington-Alexandria-Reston, VA-WV market, with the plurality of this provider's patient population coming from Arlington, VA. This provider's primary affiliated billing organization is ARTHRTITIS CLINIC OF NO. VA. (NPI: 1205051885; TIN: 541780970) and primary practice location at 22205-3606. Bilal is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Bilal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 730 traditional Medicare patients, billed 399,232 HCPCS/CPT codes, and received $3,525,452 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,833 prescription claims across 365 beneficiaries totaling $2,576,767 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 193 records totaling $11,531. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,823 to $3,525,452. Similarly, Part D prescription costs have moved sharply higher in recent years, from $306 to $2,576,767. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	56	57	$6,823
2016	N/R	N/R	N/R
2017	26	45	$3,741
2018	157	444	$31,457
2019	102	302	$22,865
2020	95	309	$23,383
2021	85	734	$24,684
2022	96	6,757	$141,063
2023	460	111,447	$1,236,184
2024	730	399,232	$3,525,452

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	12	$306
2016	N/R	11	$21,278
2017	N/R	22	$50,305
2018	64	244	$171,999
2019	52	304	$200,759
2020	59	481	$438,111
2021	62	382	$536,328
2022	44	240	$187,948
2023	180	606	$640,499
2024	365	1,833	$2,576,767

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	236	431	$146
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	537	1,041	$103
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	282	1,873	$66
J0897	Injection, denosumab, 1 mg	199	19,200	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	628	1,266	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	63	2,522	$658,451
Enbrel Sureclick	Etanercept	62	1,932	$516,140
Enbrel	Etanercept	41	1,596	$423,963
Rinvoq	Upadacitinib	27	1,050	$217,008
Orencia Clickject	Abatacept	15	644	$128,711

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	193	$11,531	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Saira Bilal, M.D.?

Tedicare shows public-source Medicare data for Saira Bilal, M.D. (NPI 1770899627), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Saira Bilal, M.D. have ACO affiliation data?

Saira Bilal, M.D. is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Saira Bilal, M.D.?

Saira Bilal, M.D. is linked to ARTHRTITIS CLINIC OF NO. VA. (billing NPI 1205051885) in the available physician profile data.

Does Saira Bilal, M.D. have Open Payments data?

Saira Bilal, M.D. has 193 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.